Turning Momentum into Scale

At bm|t, we con­ti­nue to believe that resi­li­ence is not a pas­sive qua­lity, but an active disci­pline. In a mar­ket envi­ron­ment that still demands focus, rea­lism and capi­tal effi­ci­ency, the second quar­ter of 2026 showed once again that strong teams with clear mis­si­ons can con­ti­nue to build, attract sup­port and create momentum.

Buil­ding on ear­lier reflec­tions around bold­ness and dri­ving change, this quar­ter high­ligh­ted ano­ther important dimen­sion of entre­pre­neu­rial pro­gress: the ability to trans­late momen­tum into scale. For inno­va­tive com­pa­nies, this requi­res not only tech­no­lo­gi­cal excel­lence, but also timing, trus­ted part­ner­ships and the wil­ling­ness to keep moving for­ward in dyna­mic mar­ket conditions.

Across Thü­rin­gen and bey­ond, bm|t remains com­mit­ted to sup­port­ing foun­ders and manage­ment teams who com­bine ambi­tion with disci­pli­ned exe­cu­tion. That com­mit­ment con­ti­nues to be reflec­ted in the deve­lo­p­ment of the port­fo­lio, the breadth of the finan­cing plat­form and the gro­wing visi­bi­lity of the regio­nal inno­va­tion ecosystem.

Your bm|t Team

Portfolio Developments

The second quar­ter brought encou­ra­ging signals from the bm|t port­fo­lio. Posi­tive finan­cing acti­vity, stra­te­gic eco­sys­tem visi­bi­lity and con­tin­ued ope­ra­tio­nal pro­gress across inves­tee part­ners all rein­forced the qua­lity and resi­li­ence that remain cen­tral to sus­tainable com­pany building.

A par­ti­cu­larly encou­ra­ging deve­lo­p­ment came from Smart­Dye­Li­very, which secu­red finan­cing in the mil­li­ons to sup­port its next phase of growth. The com­pany is advan­cing a plat­form around phar­maceu­ti­cal active ingre­di­ents and its fur­ther deve­lo­p­ment is being sup­ported by fresh capi­tal and an expan­ded share­hol­der base, under­li­ning con­fi­dence in the company’s tech­no­logy and mar­ket potential.

Ano­ther posi­tive signal came from neu­ro­care, one of bm|t’s inves­tee part­ners in the neu­ro­the­rapy and men­tal health space. neurocare’s posi­tio­ning around per­so­na­li­zed digi­tal the­ra­pies and non-inva­sive neu­ro­tech­no­logy con­ti­nues to reflect the type of sca­lable, high-impact health­care inno­va­tion that remains highly rele­vant within the broa­der life sci­en­ces and digi­tal health landscape.

As refe­ren­ced for this quar­ter, neu­ro­care also recei­ved EUR 2 mil­lion in finan­cing. This pro­vi­des a fur­ther posi­tive mar­ker for the company’s deve­lo­p­ment and sup­ports the view that dif­fe­ren­tia­ted men­tal health and neu­ro­tech­no­logy plat­forms con­ti­nue to attract back­ing when sup­ported by a clear pro­po­si­tion and strong execution.

Innovation Ecosystem

A fur­ther high­light of the quar­ter was the Inves­tor Days Thü­rin­gen on 11 June 2026. The event was posi­tio­ned as a plat­form to dis­co­ver inno­va­tions, create col­la­bo­ra­ti­ons and gene­rate deal flow, brin­ging tog­e­ther start­ups, inves­tors and inno­va­tion stake­hol­ders in Thüringen.

For bm|t, for­mats like Inves­tor Days Thü­rin­gen mat­ter because they do more than show­case indi­vi­dual com­pa­nies. They streng­then con­nec­ti­vity across the regio­nal eco­sys­tem, create direct access to foun­ders and tech­no­lo­gies, and help trans­late local inno­va­tion strength into broa­der finan­cing, coope­ra­tion and mar­ket opportunities.

The con­tin­ued rele­vance of such plat­forms is clo­sely ali­gned with bm|t’s man­date. Sus­tainable inno­va­tion eco­sys­tems are built not only through capi­tal, but through repea­ted inter­ac­tion bet­ween entre­pre­neurs, inves­tors, insti­tu­ti­ons and indus­trial part­ners. This is exactly where high-qua­lity regio­nal events can create dis­pro­por­tio­nate value over time.

Strong Platform, Clear Mission

With a broad invest­ment plat­form span­ning mul­ti­ple funds and finan­cing for­mats, bm|t is posi­tio­ned to sup­port inno­va­tive and growth-ori­en­ted com­pa­nies throug­hout dif­fe­rent stages of deve­lo­p­ment. This ran­ges from early-stage tech­no­logy ven­tures to later-stage and estab­lished busi­nesses pur­suing growth, trans­for­ma­tion or suc­ces­sion solutions.

In par­ti­cu­lar, bm|t was pre­viously not as well-posi­tio­ned to pro­vide growth finan­cing to lar­ger, alre­ady estab­lished Thu­rin­gian small and medium-sized enter­pri­ses. This chan­ged with the launch of the Mit­tel­stands-Fonds Thü­rin­gen II (MFT II) in 2025.

This mat­ters stra­te­gi­cally because Thüringen’s inno­va­tion strength does not end with start-ups. By com­bi­ning early-stage, growth-stage and later-stage capa­bi­li­ties, inclu­ding MFT II, bm|t can remain a relia­ble equity part­ner not only for young tech­no­logy com­pa­nies and scale-ups, but also for estab­lished medium-sized busi­nesses and the region’s hid­den champions.

Outlook

Loo­king ahead to the second half of 2026, the mar­ket envi­ron­ment is likely to remain sel­ec­tive, but con­s­truc­tive for com­pa­nies with strong posi­tio­ning, cre­di­ble mile­sto­nes and disci­pli­ned growth paths. In that con­text, Thü­rin­gen-lin­ked inno­va­tors across deep tech, health­care, indus­trial tech­no­lo­gies and other high-value niches con­ti­nue to hold attrac­tive oppor­tu­ni­ties for inves­tors and stra­te­gic partners.

Tog­e­ther with trus­ted co-inves­tors and eco­sys­tem part­ners, bm|t will con­ti­nue to sup­port port­fo­lio com­pa­nies through new invest­ments, fol­low-on finan­cing and stra­te­gic gui­dance. The com­bi­na­tion of entre­pre­neu­rial resi­li­ence, eco­sys­tem con­nec­ti­vity and a broad fund family will remain an important foun­da­tion for streng­thening Thüringen’s inno­va­tion eco­nomy in 2026 and beyond.